Skip to main navigation
Skip to search
Skip to main content
The Hebrew University of Jerusalem Home
Approve / Request updates on publications
Home
Profiles
Research units
Research output
Prizes
Search by expertise, name or affiliation
Small Molecule Modulators of Pre-mRNA Splicing in Cancer Therapy
Maayan Salton
*
, Tom Misteli
*
Corresponding author for this work
Department of Biochemistry and Molecular Biology
Research output
:
Contribution to journal
›
Review article
›
peer-review
136
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Small Molecule Modulators of Pre-mRNA Splicing in Cancer Therapy'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
In Cancer
100%
RNA Splicing
100%
Cancer Therapy
100%
Small Molecule Modulators
100%
Splicing Modulator
71%
RNA Processing
57%
Splice Isoforms
28%
Splicing Event
28%
RNA Isoforms
28%
Gene Expression
14%
Small Molecules
14%
Novel Therapeutics
14%
Therapeutic Target
14%
Cancer Types
14%
Tumor
14%
Therapeutic Strategies
14%
Alternative Splicing
14%
High Prevalence
14%
Splicing Defect
14%
Spliced RNA
14%
Cancer Treatment
14%
Addiction
14%
Drug Screening
14%
Screening Approach
14%
Protein Diversity
14%
Pre-mRNA Processing
14%
Processing Activities
14%
Effect Mechanism
14%
Undesirable Side Effects
14%
Medicine and Dentistry
Cancer Therapy
100%
RNA Splicing
100%
RNA Processing
83%
Malignant Neoplasm
50%
RNA Isoform
33%
Neoplasm
16%
Disease
16%
Gene Expression
16%
Side Effect
16%
Prevalence
16%
Addictive Behavior
16%
Alternative RNA Splicing
16%
Drug Screening
16%
Messenger RNA Precursor
16%
Splicing Defect
16%
Biochemistry, Genetics and Molecular Biology
RNA Splicing
100%
Small Molecule
100%
RNA Processing
83%
Isoform
66%
RNA
33%
Gene Expression
16%
Prevalence
16%
Alternative Splicing
16%
Splicing Defect
16%
Precursor mRNA
16%
Drug Screening
16%
Preclinical Study
16%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Messenger RNA Precursor
100%
RNA Isoform
33%
Neoplasm
16%
Disease
16%
Side Effect
16%
Prevalence
16%
Preclinical Study
16%
Drug Screening
16%
Immunology and Microbiology
RNA Splicing
100%
RNA Processing
83%
Gene Expression
16%
Prevalence
16%
Alternative RNA Splicing
16%
Splicing Defect
16%
Preclinical Study
16%
Drug Screening
16%
Neuroscience
RNA Splicing
100%
RNA Processing
83%
RNA Isoform
33%
Gene Expression
16%
Alternative Splicing
16%
Precursor mRNA
16%
Splicing Defect
16%